SUNREST — Sunrest Lifescience Income Statement
0.000.00%
- IN₹270.35m
- IN₹298.95m
- IN₹246.42m
- 25
- 47
- 43
- 29
Annual income statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 169 | 269 | 246 |
Cost of Revenue | |||
Gross Profit | 56 | 94.3 | 97.6 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 167 | 258 | 219 |
Operating Profit | 2.31 | 10.4 | 27.7 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 2.24 | 10.5 | 27.4 |
Provision for Income Taxes | |||
Net Income After Taxes | 1.65 | 7.77 | 20.4 |
Net Income Before Extraordinary Items | |||
Net Income | 1.65 | 7.77 | 20.4 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 1.66 | 7.77 | 20.4 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 0.386 | 1.77 | 4.76 |
Dividends per Share |